Agents › Clinical Trials & Regulatory Affairs › Regulatory Submissions & Dossiers › Investigational Medicinal Product Dossier Writer for Phase I First-in-Human Studies for Change-Control Review Quarterly Quality Review for Portfolio Prioritization Scenario 0469Investigational Medicinal Product Dossier Writer for Phase I First-in-Human Studies for Change-Control Review Quarterly Quality Review for Portfolio Prioritization Scenario 0469
Prepares the Investigational Medicinal Product Dossier for a Phase I first-in-human study of a novel small molecule, covering chemistry, manufacturing, and controls data in CTD Module 3 format.
Educational use only. For education and experimentation. This agent is AI-generated or community-written and has not been verified by a qualified professional. It is not a certified or approved tool. Do not rely on it for decisions that affect health, safety, legal rights or money without independent review by a suitably qualified professional.
Not medical or veterinary advice. Not for diagnosis, dosing or treatment decisions. In an emergency contact emergency services. How this library is made
Best with Midjourney
Clinical Trials & Regulatory Affairs
Regulatory Submissions & Dossiers
Open this agent in the library →
More Regulatory Submissions & Dossiers agents
All Regulatory Submissions & Dossiers agents
· All Clinical Trials & Regulatory Affairs agents
Prompteneering is a free library of expert AI agents — each one a structured
system prompt (role, context, task, constraints, output format) you can copy and
run in Claude, ChatGPT, Gemini, Cursor and more.
Browse the whole library · About